Close Menu

IBM

The University of Warsaw's Interdisciplinary Center for Mathematical and Computational Modeling had selected IBM's Blue Gene/Q Supercomputer to support a biomedical and biotechnological research initiative aimed at developing new drugs and therapies for several ailments including

US Patent 8, 374,837. Descriptors of three-dimensional objects, uses thereof and a method to generate the same. Inventors: Hans Louis Jos De Winter, Roger Gert Wilfried Langenaeker. Assignee: Silicos

Originally published Jan. 29.
MOUNTAIN VIEW, Calif. – The Coriell Institute for Medical Research in partnership with IBM has launched a for-profit company that will store consumers' whole-genome sequencing data.

Increasing activity from sequencing vendors and other new players, as well as a flurry of activity around clinical data analysis software and the commercialization of a number of open source tools were the key trends in the bioinformatics community in 2012.

Australia's Victorian Life Sciences Computation Initiative hosts the fastest life science supercomputer in the world, according to the most recent version of the Top500 list released earlier this month.

US Patent 8,275,557. Computer-implemented method and computer-based system for validating DNA sequencing data. Inventor: Stefan Emler. Assignee: SmartGene
Describes a computerized method of validating DNA fragments using reference sequences.

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

This week, Philip Morris International and IBM, organizers of the Industrial Methodology for Process Verification in Research, or IMPROVER, initiative, announced the winners of the first of a series of planned challenges aimed at developing a transparent and robust process for ve

The University of Pittsburgh Medical Center said this week that it plans to invest $100 million over five years in informatics infrastructure, training, and support aimed at making personalized medicine a reality.

NEW YORK (GenomeWeb News) – Non-profit health system UPMC today announced a five-year $100 million investment to establish an enterprise analytics initiative to foster personalized medicine.

Pages

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.